Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
ketotifen "orifarm" 0,25 mg/ml øjendråber, opløsning
orifarm a/s - ketotifenhydrogenfumarat - øjendråber, opløsning - 0,25 mg/ml
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
ketotifen "paranova" 0,25 mg/ml øjendråber, opløsning, enkeltdosisbeholder
paranova danmark a/s - ketotifenhydrogenfumarat - øjendråber, opløsning, enkeltdosisbeholder - 0,25 mg/ml
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
zaditen 0,25 mg/ml øjendråber, opløsning
laboratoires thea s.a.s. - ketotifenhydrogenfumarat - øjendråber, opløsning - 0,25 mg/ml
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
zaditen 0,25 mg/ml øjendråber, opløsning
2care4 aps - ketotifenhydrogenfumarat - øjendråber, opløsning - 0,25 mg/ml
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
zaditen 0,25 mg/ml øjendråber, opløsning, enkeltdosisbeholder
laboratoires thea s.a.s. - ketotifenhydrogenfumarat - øjendråber, opløsning, enkeltdosisbeholder - 0,25 mg/ml